Condition: Erectile Dysfunction · Hypogonadism, Male · Endothelial Dysfunction · Sponsor: University of California, Irvine
To assess endothelial dysfunction in young men (aged 30-50) with vasculogenic ED identified through penile Doppler ultrasound. To evaluate changes in endothelial function using EndoPAT before and 3-6 months after daily low-dose phosphodiesterase type 5 (PDE5) inhibitor therapy. To investigate endothelial function alterations in hypogonadal patients before and 3-6 months after initiating testosterone (T) therapy
This description comes directly from the study's public registry record.
Muhammed AM Hammad, MBBCh · 714-456-7005 · mahammad@hs.uci.edu
Elia Abou Chawareb, MD · 714-456-7005 · eaboucha@hotmail.com
Always discuss trial participation with your own doctor first.
| UCI Urology | Men's Health Center | Newport Beach, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06720597